Short-term control of tyrosine hydroxylase.
D000313:Adrenal Medulla / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001369:Axons / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D002714:Chlorisondamine / Q000494:pharmacology; D003342:Corpus Striatum / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000096:biosynthesis; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006220:Haloperidol / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000096:biosynthesis; D010293:Pargyline / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D008996:Monoamine Oxidase Inhibitors; D004295:Dihydroxyphenylalanine; D001285:Atropine; D010293:Pargyline; D010830:Physostigmine; D014446:Tyrosine 3-Monooxygenase; D006220:Haloperidol; D002714:Chlorisondamine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine